ETF Outflow Alert: XBI, EXAS, RVMD, RNA Experience $140.4 Million Share Decrease

The SPDR S&P Biotech ETF (XBI) experienced a $140.4 million outflow, a 1.7% decrease from last week. The ETF's holdings include EXACT Sciences Corp. (EXAS), Revolution Medicines Inc. (RVMD), and Avidity Biosciences Inc. (RNA). The one-year price performance of XBI is shown in the chart, with a 52-week range of $66.66 to $125.87. The ETF's outflow may impact its underlying holdings, and other ETFs experienced notable outflows this week.